A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)

NCT02871401 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Valganciclovir
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]